Overview

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Criteria
Inclusion Criteria:

- Female patients with endometriosis

Exclusion Criteria:

- Patients with clinically significant hepatic, renal, or cardiovascular dysfunction